Press Releases

News

‘Super T Cells’ Engineered for Optimal Performance Drive New Roswell Park Gene-Therapy Approach

Researchers at Roswell Park Comprehensive Cancer Center have initiated a clinical trial based on a unique two-pronged strategy for arming the immune system to more effectively attack cancer cells. Patients treated through this early-stage clinical trial, which is available only at Roswell Park, will receive one-time injections of their own cells —“super T cells” reprogrammed to make them more effective at targeting tumor cells, and armed with an added element to help them to evade one of cancer’s most resilient defenses.
News

Sustained Top 5% Ranking for Inpatient Satisfaction Earns Roswell Park A Coveted National Distinction

Roswell Park Comprehensive Cancer Center has again been honored by the Press Ganey organization for consistent superior performance in the area of patient experience. The comprehensive cancer center has received Press Ganey’s Guardian of Excellence Award for the third year in a row based on its sustained ranking among the top 5% of hospitals for patient satisfaction related to inpatient care.

News

Viral Vector Mobilan Offers a New Approach for Cancer Immunotherapy

One of the most important areas of cancer research today involves efforts to expand the benefits of immunotherapy to more patients. Research conducted by scientists at Roswell Park Comprehensive Cancer Center in cooperation with Panacela Labs LLC, a subsidiary of Cleveland BioLabs LLC (Nasdaq: CBLI), introduces a new class of immunotherapy and proposes a strategy for increasing the number of patients who are likely to benefit from this new approach.
News

Roswell Park Patients Will Have Expanded Access to Medical Records Through NYS Health Foundation Grant

A newly awarded grant will enable easier, more interactive access to medical records for Roswell Park Comprehensive Cancer Center patients. The comprehensive cancer center will become one of the first centers anywhere in New York State to implement the OpenNotes concept and integrate note-sharing into its secure digital portal, MyRoswell, thanks to a $125,000 award from the New York State Health Foundation.

News

The Oncogene FOXQ1 Promotes Some Tumor Types but Suppresses Another

BUFFALO, N.Y. — A treatment that works well for one cancer type can possibly make other cancers grow more quickly. That is the striking implication of new research from a team at Roswell Park Comprehensive Cancer Center, published in the journal Cell Reports.